Strategies for Patient Adherence to Blood Pressure Management Therapies
Daniel Edmundowicz, MS, MD, FACP, FACC, Chief, Cardiology, Temple University Hospital discusses the challenges of maintaining long-term adherence of preventative medications for hypertension.
Hard-to-control Hypertension and When to Consider a Referral to Advanced Program for Complex Hypertension
Ajaykumar D. Rao, MD, MMSc, FACP, discusses the complexity of patients with resistant hypertension and secondary hypertension, and when patients benefit from a referral to clinical hypertension experts.
Optimal Pharmaceuticals to Support Blood Pressure Management
Paul H. Pronovost, MD, FACP, FASN; Interim Chief, Section of Nephrology, Hypertension and Kidney Transplantation at the Lewis Katz School of Medicine at Temple University discusses challenges in the medical management of hypertension.
CTEPH Diagnosis and Management in 2022: Grand Rounds with Dr. Anjali Vaidya
Anjali Vaidya, MD, FACC, FASE, FACP, Co-Director of Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple Health shares advanced diagnosis and managment for chronic thromboembolic pulmonary hypertension.
Advanced Diagnosis and Therapy for Paroxysmal Atrial Fibrillation and Chronic Blood Loss Anemia
78-year-old Temple Heart & Vascular patient regains life with WATCHMAN device
Advanced Diagnosis and Therapy for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in 20-year-old patient
A healthy, 20-year-old male from Georgia began suffering from shortness of breath, chest pain, and syncope. Patient had no known history of DVT or PE, but a CT scan revealed 'extensive pulmonary emboli.'
Advanced Diagnosis and Therapy for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in 69-year-old Patient
Paul B. was 69 years old when he sought out care in 2017 for worsening shortness of breath that was limiting his daily activities.
Aortic dissection involving the ascending aorta (type A) is a life-threatening emergency that should usually be treated surgically. In type A dissections, mortality can be up to 80%, and can be reduced to 10-20% through surgical treatment.
Referral Protocol for Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple
When it comes to identifying and treating the complex causes of pulmonary hypertension and its and affiliated conditions, the Temple Heart & Vascular Institute is the clear choice for your patients.
Successful Surgical Repair of Giant Left Ventricular Aneurysm With Porcelain Left Ventricle
Dr. Kewal Krishan, a senior cardiac surgeon at Temple Health, reviews successful repair of calcific left ventricular aneurysm with with porcelain ventricle.